Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery resulted in stroke survivors being more likely to have better function 90 days ...

Recent research has revealed compelling evidence supporting tenecteplase as a more effective treatment for ischemic strokes compared to traditional alteplase therapy. This discovery could mark a major ...

PRAGUE, Czech Republic — A 0.4-mg/kg bolus dose of tenecteplase (TNKase, Genentech) was associated with functional outcomes and safety similar to those seen with the standard of care, alteplase ...

Patients with an ischemic stroke treated with tenecteplase have almost a 50% lower rate of symptomatic intracranial hemorrhage (sICH) compared with those receiving alteplase, preliminary results from ...

At 4:40 a.m. on May 4, 2026, a 40-year-old man came to Khanna Sub-divisional Hospital’s emergency department with sweating and chest pain. Within minutes, the staff nurse and Emergency Medical Officer ...